about
Effect of large weight reductions on measured and estimated kidney function.Bariatric surgery - effects on obesity and related co-morbidities.Updates in weight loss surgery and gastrointestinal peptides.Emerging drugs for the treatment of obesity.In vivo and in vitro degradation of peptide YY3-36 to inactive peptide YY3-34 in humans.Chenodeoxycholic acid stimulates glucagon-like peptide-1 secretion in patients after Roux-en-Y gastric bypass.Circulating Glucagon 1-61 Regulates Blood Glucose by Increasing Insulin Secretion and Hepatic Glucose Production.Nutrient re-routing and altered gut-islet cell crosstalk may explain early relief of severe postprandial hypoglycaemia after reversal of Roux-en-Y gastric bypass.Variable reliability of surrogate measures of insulin sensitivity after Roux-en-Y gastric bypass.Peptide YY and glucagon-like peptide-1 contribute to decreased food intake after Roux-en-Y gastric bypass surgery.No Islet Cell Hyperfunction, but Altered Gut-Islet Regulation and Postprandial Hypoglycemia in Glucose-Tolerant Patients 3 Years After Gastric Bypass Surgery.Mechanisms in bariatric surgery: Gut hormones, diabetes resolution, and weight loss.[Medical therapy versus bariatric surgery of obese patients with Type 2 diabetes]Effects of endogenous GLP-1 and GIP on glucose tolerance after Roux-en-Y gastric bypass surgeryMechanisms of action of a carbohydrate-reduced, high-protein diet in reducing the risk of postprandial hypoglycemia after Roux-en-Y gastric bypass surgeryGut Hormones and Their Effect on Bone Metabolism. Potential Drug Therapies in Future Osteoporosis TreatmentPerineal hernia after laparoscopic abdominoperineal resection--reconstruction of the pelvic floor with a biological mesh (Permacol™)Sustained Improvements in Glucose Metabolism Late After Roux-En-Y Gastric Bypass Surgery in Patients with and Without Preoperative DiabetesIntestinal sensing and handling of dietary lipids in gastric bypass-operated patients and matched controlsEffect of bariatric surgery on plasma GDF15 in humansPostprandial Nutrient Handling and Gastrointestinal Hormone Secretion After Roux-en-Y Gastric Bypass vs Sleeve GastrectomyGLP-2 and GIP exert separate effects on bone turnover: A randomized, placebo-controlled, crossover study in healthy young menAugmented GLP-1 Secretion as Seen After Gastric Bypass May Be Obtained by Delaying Carbohydrate Digestion[Successful treatment of KCNJ11 neonatal diabetes without insulin]Plasma FGF-19 Levels are Increased in Patients with Post-Bariatric Hypoglycemia
P50
Q37628031-7411393A-9F6B-4632-9931-1F2AC01D2E7BQ38220647-E5D2A30C-CD8B-444B-824E-6381651F6C72Q38291603-7F056FF2-60CF-42FE-B81B-B694278DB252Q39031756-AD9F5E67-0107-4A9B-89EE-324F000E3F12Q40953070-A3F08C0C-233E-4F60-AD6D-639D80BDDB29Q41909990-851F15D9-63E2-4793-B378-84FF957E44C6Q47115664-E8B4A1AB-9BAB-4238-8762-A14055DF2FCAQ48056477-36BF46C8-BCDC-431E-8F22-A54FFCDC4F8AQ48233068-1101432B-9E4A-445D-B733-52E9D6B5F610Q53589377-1E5DE589-5FCB-4CF0-BE07-9C3837EA735BQ53787715-510F2E69-4235-4E17-ADF5-B86E6F3729B2Q55081525-ABCFFB5A-4E3A-449D-A07C-0E1CE9011169Q58167155-975DABA4-5E8B-45C1-A757-0DAE53EA6C66Q58167278-B3EABAC3-3F8E-4745-A152-E4B604D4E27EQ63379394-1B0C52A5-1AA7-4E5C-89AA-BC757217CF4DQ64100375-66566FAA-D56D-45A6-A930-FAAE21F7E6F5Q84325509-0208BB8E-BA8E-40EC-B76F-5129E9C99D7DQ90884287-A0EEFACD-54EC-42FD-8729-990787E889A6Q91335472-F06F8D39-0DA9-4C23-A313-C778E75F8362Q91351053-9A3F864D-67B6-4B98-8BB9-3F2F172FB8F3Q91454965-09A29D7C-CEC0-46E2-B29F-273B5E57F2B3Q92116235-67D23657-7358-4ED2-8EE1-3E12EB8CA0BEQ92189936-246E2D4D-6D14-47C5-9AD7-BCDF4E722911Q92998075-83D75C5C-1508-43F0-A8A8-B57C555D2C9DQ93047876-0DAC356B-EBD3-434A-B98B-3973CEF7163B
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Maria S Svane
@ast
Maria S Svane
@en
Maria S Svane
@es
Maria S Svane
@nl
type
label
Maria S Svane
@ast
Maria S Svane
@en
Maria S Svane
@es
Maria S Svane
@nl
prefLabel
Maria S Svane
@ast
Maria S Svane
@en
Maria S Svane
@es
Maria S Svane
@nl
P106
P21
P31
P496
0000-0002-7345-4471